BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10326114)

  • 1. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators.
    Chippaux JP; Lang J; Eddine SA; Fagot P; Rage V; Peyrieux JC; Le Mener V
    Trans R Soc Trop Med Hyg; 1998; 92(6):657-62. PubMed ID: 10326114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short report: treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab)2: results of a clinical trial in northern Cameroon.
    Chippaux JP; Lang J; Amadi-Eddine S; Fagot P; Le Mener V
    Am J Trop Med Hyg; 1999 Dec; 61(6):1017-8. PubMed ID: 10674688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
    Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD
    Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Snake bite by European vipers. A multicenter study of tolerance to Viperfav, a new intravenous antivenom].
    de Haro L; Lang J; Bedry R; Guelon D; Harry P; Marchal-Mazet F; Jouglard J
    Ann Fr Anesth Reanim; 1998; 17(7):681-7. PubMed ID: 9750806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
    Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of tolerance and effectiveness of a F(ab')(2) polyvalent antienom for African snake bites in Kindia, Guinea].
    Baldé MC; Chippaux JP; Boiro MY; Stock R; Massougbodji A
    Bull Soc Pathol Exot; 2012 Aug; 105(3):157-61. PubMed ID: 22359185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of an F(ab')2 polyvalent equine antivenom for African snake bites in Benin.
    Chippaux JP; Massougbodji A; Stock RP; Alagon A;
    Am J Trop Med Hyg; 2007 Sep; 77(3):538-46. PubMed ID: 17827375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of intravenous equine F(ab')2: insights following clinical trials involving 1534 recipients of scorpion antivenom.
    Boyer L; Degan J; Ruha AM; Mallie J; Mangin E; Alagón A
    Toxicon; 2013 Dec; 76():386-93. PubMed ID: 23916602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming.
    Karlson-Stiber C; Persson H; Heath A; Smith D; al-Abdulla IH; Sjöström L
    J Intern Med; 1997 Jan; 241(1):53-8. PubMed ID: 9042094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
    Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
    Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snake bites by European vipers in Mainland France in 2017-2018: comparison of two antivenoms Viperfav
    Boels D; Hamel JF; Le Roux G; Labadie M; Paret N; Delcourt N; Langrand J; Puskarczyk E; Nisse P; Sinno-Tellier S; de Haro L
    Clin Toxicol (Phila); 2020 Nov; 58(11):1050-1057. PubMed ID: 32134691
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent and persistent coagulopathy following pit viper envenomation.
    Boyer LV; Seifert SA; Clark RF; McNally JT; Williams SR; Nordt SP; Walter FG; Dart RC
    Arch Intern Med; 1999 Apr; 159(7):706-10. PubMed ID: 10218750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')
    Gerardo CJ; Vissoci JR; Brown MW; Bush SP
    Clin Toxicol (Phila); 2017 Feb; 55(2):109-114. PubMed ID: 27806644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antivenom treatment in Vipera berus envenoming--report of 30 cases.
    Karlson-Stiber C; Persson H
    J Intern Med; 1994 Jan; 235(1):57-61. PubMed ID: 8283161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of early reactions to horse-derived F(ab')(2) antivenom for snakebites in Thailand.
    Thiansookon A; Rojnuckarin P
    Acta Trop; 2008 Feb; 105(2):203-5. PubMed ID: 17996842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
    Boels D; Hamel JF; Bretaudeau Deguigne M; Harry P
    Clin Toxicol (Phila); 2012 Mar; 50(3):189-96. PubMed ID: 22372786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective multicenter observational study of Viperidae polyvalent immune F(ab')
    Vanni M; Intorre L; Corazza M; Meucci V; Parti S
    J Vet Emerg Crit Care (San Antonio); 2020 Jan; 30(1):34-40. PubMed ID: 31858721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 272 cases of rattlesnake envenomation in dogs: Demographics and treatment including safety of F(ab')2 antivenom use in 236 patients.
    Witsil AJ; Wells RJ; Woods C; Rao S
    Toxicon; 2015 Oct; 105():19-26. PubMed ID: 26341419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Rattlesnake Envenomations Treated With Crotalidae Equine Immune F(Ab') 2 Antivenom : A 3-Year Retrospective Observational Analysis.
    Seltzer JA; Winkler GA; Friedman NA; Galust H; Hardin J; Srihari P; Ontiveros S; Corbett B; Clark RF
    Pediatr Emerg Care; 2023 Oct; 39(10):776-779. PubMed ID: 37725768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab')2] antivenoms, in Bothrops asper bites in Colombia.
    Otero-Patiño R; Segura A; Herrera M; Angulo Y; León G; Gutiérrez JM; Barona J; Estrada S; Pereañez A; Quintana JC; Vargas LJ; Gómez JP; Díaz A; Suárez AM; Fernández J; Ramírez P; Fabra P; Perea M; Fernández D; Arroyo Y; Betancur D; Pupo L; Córdoba EA; Ramírez CE; Arrieta AB; Rivero A; Mosquera DC; Conrado NL; Ortiz R
    Toxicon; 2012 Feb; 59(2):344-55. PubMed ID: 22146491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.